Time-release history of the opioid epidemic /

Saved in:
Bibliographic Details
Author / Creator:Campbell, J. N., author.
Imprint:Cham : Springer, [2018]
Description:1 online resource (xviii, 134 pages) : illustrations, portraits
Language:English
Series:SpringerBriefs in Molecular Science, 2191-5407
SpringerBriefs in molecular science,
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11664227
Hidden Bibliographic Details
Other authors / contributors:Rooney, Steven M., author.
ISBN:9783319917887
3319917889
3319917870
9783319917870
9783319917870
3319917870
Digital file characteristics:text file PDF
Notes:Includes bibliographical references and index.
Summary:This Brief takes the reader on a chemical journey by following the history for over two centuries of how an opiate became an opioid, thus spawning an empire and a series of crises. These imperfect resemblances of alkaloids are both natural and synthetic substances that, particularly in America, are continually part of a growing concern about overuse. This seemed an inviting prospect for those in pain, but as the ubiquitous media coverage continues to lay bare, the levels of abuse point to the fact that perhaps an epidemic is upon us, if not a culture war. Seeking answers to how and why this addiction crisis transpired over two hundred years of long development, this Brief examines the role that the chemistry laboratory played in turning patients into consumers. By utilizing a host of diverse sources, this Brief seeks to trace the design and the production of opioids and their antecedents over the past two centuries. From the isolation and development of the first alkaloids with morphine that relieved pain within the home and on the battlefield, to the widespread use of nostrums and the addiction crisis that ensued, to the dissemination of drugs by what became known as Big Pharma after the World Wars; and finally, to competition from home-made pharmaceuticals, the progenitor was always, in some form, a type of chemistry lab. At times, the laboratory pressed science to think deeply about society's maladies, such as curing disease and alleviating pain, in order to look for new opportunities in the name of progress. Despite the best intentions opioids have created a paradox of pain as they were manipulated by creating relief with synthetic precision and influencing a dystopian vision. Thus, influence came in many forms, from governments, from the medical community, and from the entrepreneurial aspirations of the general populace. For better, but mostly for worse, all played a role in changing forever the trajectory of what started with the isolation of a compound in Germany. Combining chemistry and history in a rousing new long-form narrative that even broadens the definition of a laboratory, the origins and future of this complicated topic are carefully examined.
Other form:Printed edition: 9783319917870
Standard no.:10.1007/978-3-319-91788-7
9783319917870

MARC

LEADER 00000cam a2200000Ii 4500
001 11664227
005 20210625184959.1
006 m o d
007 cr nn||||mamaa
008 180609s2018 sz a ob 001 0 eng d
015 |a GBB8K7346  |2 bnb 
016 7 |a 019109925  |2 Uk 
019 |a 1040072358  |a 1040998529  |a 1041479344  |a 1041831740  |a 1041880291  |a 1058965083  |a 1059008567  |a 1066477503  |a 1073080373  |a 1081233264  |a 1082867694  |a 1085187257  |a 1097101085 
020 |a 9783319917887 
020 |a 3319917889 
020 |a 3319917870 
020 |a 9783319917870 
020 |z 9783319917870 
020 |z 3319917870 
024 7 |a 10.1007/978-3-319-91788-7  |2 doi 
024 3 |a 9783319917870 
035 |a (OCoLC)1040652075  |z (OCoLC)1040072358  |z (OCoLC)1040998529  |z (OCoLC)1041479344  |z (OCoLC)1041831740  |z (OCoLC)1041880291  |z (OCoLC)1058965083  |z (OCoLC)1059008567  |z (OCoLC)1066477503  |z (OCoLC)1073080373  |z (OCoLC)1081233264  |z (OCoLC)1082867694  |z (OCoLC)1085187257  |z (OCoLC)1097101085 
035 9 |a (OCLCCM-CC)1040652075 
037 |a 9783319917870  |b 00024965 
040 |a AZU  |b eng  |e rda  |e pn  |c AZU  |d OCLCO  |d N$T  |d GW5XE  |d N$T  |d YDX  |d EBLCP  |d OCLCF  |d UAB  |d UPM  |d MERER  |d OCLCQ  |d VT2  |d OH1  |d OCLCO  |d AU@  |d CNCEN  |d OCLCO  |d WYU  |d OCLCA  |d OCLCQ  |d NOC  |d OCLCO  |d UKMGB  |d OTZ  |d LVT  |d OCLCO  |d U3W  |d OCLCQ  |d CAUOI  |d NOC  |d OCLCO  |d OCLCQ  |d OCLCO  |d COO  |d OCLCO  |d SNK  |d OCLCQ  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d OCL  |d OCLCO 
043 |a n-us--- 
049 |a MAIN 
050 4 |a RA1242.N3 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
072 7 |a PN  |2 bicssc 
072 7 |a PDX  |2 bicssc 
100 1 |a Campbell, J. N.,  |e author.  |0 http://id.loc.gov/authorities/names/n2017189365 
245 1 0 |a Time-release history of the opioid epidemic /  |c J.N. Campbell, Steven M. Rooney. 
264 1 |a Cham :  |b Springer,  |c [2018] 
300 |a 1 online resource (xviii, 134 pages) :  |b illustrations, portraits 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a SpringerBriefs in Molecular Science,  |x 2191-5407 
504 |a Includes bibliographical references and index. 
505 0 |a Introduction: Chemical Heterotopias -- Part One: Alkaloid Heterotopias -- Part Two: Synthetic Opiate Heterotopias -- Epilogue: Opioid Heterotopias. 
520 |a This Brief takes the reader on a chemical journey by following the history for over two centuries of how an opiate became an opioid, thus spawning an empire and a series of crises. These imperfect resemblances of alkaloids are both natural and synthetic substances that, particularly in America, are continually part of a growing concern about overuse. This seemed an inviting prospect for those in pain, but as the ubiquitous media coverage continues to lay bare, the levels of abuse point to the fact that perhaps an epidemic is upon us, if not a culture war. Seeking answers to how and why this addiction crisis transpired over two hundred years of long development, this Brief examines the role that the chemistry laboratory played in turning patients into consumers. By utilizing a host of diverse sources, this Brief seeks to trace the design and the production of opioids and their antecedents over the past two centuries. From the isolation and development of the first alkaloids with morphine that relieved pain within the home and on the battlefield, to the widespread use of nostrums and the addiction crisis that ensued, to the dissemination of drugs by what became known as Big Pharma after the World Wars; and finally, to competition from home-made pharmaceuticals, the progenitor was always, in some form, a type of chemistry lab. At times, the laboratory pressed science to think deeply about society's maladies, such as curing disease and alleviating pain, in order to look for new opportunities in the name of progress. Despite the best intentions opioids have created a paradox of pain as they were manipulated by creating relief with synthetic precision and influencing a dystopian vision. Thus, influence came in many forms, from governments, from the medical community, and from the entrepreneurial aspirations of the general populace. For better, but mostly for worse, all played a role in changing forever the trajectory of what started with the isolation of a compound in Germany. Combining chemistry and history in a rousing new long-form narrative that even broadens the definition of a laboratory, the origins and future of this complicated topic are carefully examined. 
650 0 |a Opioids  |x History. 
650 0 |a Opioid abuse  |x History. 
650 0 |a Analgesics industry.  |0 http://id.loc.gov/authorities/subjects/sh91005868 
650 1 2 |a Opioid-Related Disorders  |x history. 
650 1 2 |a Analgesics, Opioid  |x history. 
650 2 2 |a Pharmaceutical Research  |x history. 
650 2 2 |a Drug Industry  |x history. 
650 2 2 |a Chemistry, Pharmaceutical  |x history. 
650 2 2 |a History, Modern 1601-. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Organic chemistry.  |2 bicssc 
650 7 |a History of medicine.  |2 bicssc 
650 7 |a Pharmacology.  |2 bicssc 
650 7 |a Psychopharmacology.  |2 bicssc 
650 7 |a Chemistry.  |2 bicssc 
650 7 |a Opioids.  |2 fast  |0 (OCoLC)fst01046544 
650 7 |a Opioid abuse.  |2 fast  |0 (OCoLC)fst01430929 
650 7 |a Analgesics industry.  |2 fast  |0 (OCoLC)fst00808281 
650 7 |a Drug addiction.  |2 fast  |0 (OCoLC)fst01430217 
650 7 |a Narcotics.  |2 fast  |0 (OCoLC)fst01032860 
650 7 |a Narcotics  |x Overdose.  |2 fast  |0 (OCoLC)fst01430815 
655 0 |a History. 
655 4 |a Electronic books. 
655 7 |a History.  |2 fast  |0 (OCoLC)fst01411628 
700 1 |a Rooney, Steven M.,  |e author.  |0 http://id.loc.gov/authorities/names/n2017189363 
776 0 8 |i Printed edition:  |z 9783319917870  |w (OCoLC)1031449303 
830 0 |a SpringerBriefs in molecular science,  |x 2191-5407  |0 http://id.loc.gov/authorities/names/no2011179477 
903 |a HeVa 
929 |a oclccm 
999 f f |i 5a62d7ac-ee22-58b5-b672-aa50e45f82d3  |s 1780fe4a-53a7-5518-bb4a-3c4ec0ab1333 
928 |t Library of Congress classification  |a RA1242.N3  |l Online  |c UC-FullText  |u https://link.springer.com/10.1007/978-3-319-91788-7  |z Springer Nature  |g ebooks  |i 12554781